Amarin | AMRN - Eps Gewinn Pro Aktie





Eps Veränderung Datum
AbbVie USD 3.65 1 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amarin USD 0.14 0.06 2025-12
AstraZeneca USD 2.63 0.05 2026-06
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
DBV Technologies USD -0.55 0.31 2026-03
GlaxoSmithKline GBP 0.51 0.08 2026-06
Halozyme Therapeutics USD 1.6 1.84 2026-03
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06